Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRS01 in Active Non-infectious Anterior Uveitis
NCT05042609Phase 3Completed
- Sponsor
- Tarsier Pharma
- Start
- Sep 2021
- Primary completion
- Jun 2023
- Modality
- Peptides, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of dazdotuftide in uveitic glaucoma, sponsored by Tarsier Pharma. Started Sep 2021; status: completed.
02
Drugs
dazdotuftide
03
Conditions
uveitic glaucoma
Beyond the preview
Go deeper on NCT05042609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05042609.